Horizon Medical Products, Inc. Receives FDA Clearance For Its Vortex MP Port System.Business Editors/Health/Medical Writers ATLANTA--(BUSINESS WIRE)--Sept. 30, 2003 New Vortex MP Offers Features Long Sought by Oncologists, Patients, and Implanting Physicians Horizon Medical Products, Inc. (AMEX AMEX See: American Stock Exchange : HMP HMP - hybrid multiprocessing ) announced today, that it has received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. clearance for the Vortex(R) MP Peripheral Access Port to further expand its family of vascular access vascular access Clinical medicine The ability to enter the vascular system; the ease with which the vascular system can be entered for administering therapy or obtaining blood for testing ports. Ports are used for the infusion of medications, blood and nutrients and can also be used for blood sampling. The Vortex(R) MP is ideally suited for peripheral use and is the first port in the Vortex(R) family to include the FluoroMax(TM) and PeelPro(TM) features. The Vortex(R) MP is expected to be launched in November 2003. ABOUT HORIZON MEDICAL PRODUCTS Horizon Medical Products, Inc. headquartered in Atlanta, is a world leader in design, development, manufacture and sale of technologically advanced, high value-added, percutaneous vascular and spinal access systems. The Company's oncology product lines include implantable ports, some of which feature its proprietary VTX VTX Videotex VTX Virginia Tech X-Ray Crystallography Laboratory VTX Voice Transmit Mode VTX Video Text (R) technology; tunneled central venous catheters; and stem-cell transplant catheters used primarily in cancer treatment protocols. The Company also markets a complete line of acute and chronic dialysis catheters. In June 2003, the Company gained exclusive U.S. rights to distribute Medtonic Inc.'s Hepatic Arterial Infusion (HAI HAI Health Action International HAI Healthcare-Associated Infections HAI Helicopter Association International HAI Hospital Acquired Infection HAI Hemagglutination Inhibition (Immune assay type, microbiology) ) product line, including sales and case support of Medtronic's IsoMed(R) Infusion System and related products. Its Internet address is www.hmpvascular.com. SAFE HARBOR Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Certain statements and information included herein may constitute "forward-looking statements" which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The forward-looking statements are based on current expectations and may be significantly impacted by certain risks and uncertainties described herein and various documents filed by the Company with the U.S. Securities and Exchange Commission, including but not limited to the Company's Prospectus on Form S-1 and the Company's Annual Report on Form 10-K for the year ended December 31, 2002 and the Company's Quarterly Reports on Form 10-Q. There can be no assurances that statements made in this press release relating to future events will be achieved. The Company undertakes no obligations to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion